Measuring patient-reported outcomes: moving beyond misplaced common sense to hard science
- PMID: 21756344
- PMCID: PMC3170214
- DOI: 10.1186/1741-7015-9-86
Measuring patient-reported outcomes: moving beyond misplaced common sense to hard science
Abstract
Interest in the patient's views of his or her illness and treatment has increased dramatically. However, our ability to appropriately measure such issues lags far behind the level of interest and need. Too often such measurement is considered to be a simple and trivial activity that merely requires the application of common sense. However, good quality measurement of patient-reported outcomes is a complex activity requiring considerable expertise and experience. This review considers the most important issues related to such measurement in the context of chronic disease and details how instruments should be developed, validated and adapted for use in additional languages. While there is often consensus on how best to undertake these activities, there is generally little evidence to support such accord. The present article questions these orthodox views and suggests alternative approaches that have been shown to be effective.
Figures
References
-
- World Health Organization. International Classification of Impairments, Disabilities and Handicaps: A Manual of Classification Relating to Consequences of Disease. Geneva: World Health Organization; 1980.
-
- World Health Organization. International Classification of Functioning, Disability and Health. Geneva: World Health Organization; 2001.
-
- Acquadro C, Berzon R, Dubois D, Leidy NK, Marquis P, Revicki D, Rothman M. PRO Harmonization Group. Incorporating the patient's perspective into drug development and communication: an ad hoc task force report on the patient-reported outcomes (PRO) harmonization group meeting at the Food and Drug Administration, February 16, 2001. Value Health. 2003;5:522–531. - PubMed
-
- EMEA; Committee for Medicinal Products for Human Use (CMHP) Doc Ref EMEA/CHMP/EWP/139391/2004. London: European Medicines Agency; 2005. Reflection paper on the regulatory guidance for the use of health-related quality of life (HRQL) measures in the evaluation of medicinal products.http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guidelin...
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
